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Summary
Objectives: The aim of this study was to illustrate and help address a growing need for regulatory
ormolecular tools to track and control the spread of canine brucellosis. Our study objectives were
to first characterize Brucella canis outbreaks in Wisconsin kennels in the context of the dog trade
in the USA, and then to identify a molecular technique that may be useful for strain differentia-
tion of B. canis isolates.
Methods: Wisconsin Veterinary Diagnostic Laboratory (WVDL) B. canis serology data from 1995 to
2005 were reviewed, three canine brucellosis outbreaks in Wisconsin dog kennels were inves-
tigated, and eight B. canis isolates recovered from Wisconsin outbreaks and kennels in Missouri
and Arkansas and four isolates received from outside sources were subjected to ribotyping,
pulsed-field gel electrophoresis (PFGE), outer membrane protein analysis (OMPA), and cellular
fatty acid profiling (CFAP).
Results: WVDL has received increasing numbers of B. canis positive samples from Wisconsin
kennels, and Wisconsin outbreaks are associated with the interstate dog trade. All of the B. canis
isolates we examined were genetically homogenous and as such could not be differentiated by
ribotyping, PFGE and OMPA. However, dendrogram analysis of CFAP divided the isolates into two
groups, indicating that CFAP methyl ester analysis has discriminatory power.
Conclusions: CFAP methyl ester analysis has promise as a tool for epidemiological tracing of B.
canis outbreaks and will be useful in comparison studies as isolation of B. canis continues to expand
globally.
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Brucella canis is a bacterial disease of dogs that is orally and
sexually transmitted. The disease causes epididymitis and
orchitis in male dogs, endometritis, placentitis and abortions
in females, and often presents as infertility in both sexes.
Non-reproductive lesions are less common and include
inflammation in eyes and axial and appendicular skeleton,
lymphadenopathy and splenomegaly.1—5
Since it was first isolated in 1966,1 B. canis has commonly
been reported in Central and South America, has been
identified in breeding kennels in China and Japan, and has
become a major source of economic loss in large and small
dog breeding facilities in the USA. A single outbreak occurring
in a large breeding facility can lead to the euthanasia of
hundreds of dogs. Clear identification of outbreak sources is
rarely achieved because of poorly documented sales and
breeding practices, absence of regulated testing for B. canis,
and a delay in clinical evidence of infection.
Human infection with B. canis is generally considered
uncommon and mild,2,4,5 but reports have suggested that
inappropriate serologic testing for the disease in humans has
led to misconceptions concerning prevalence.6—8 Human
cases have occurred through exposure to infected dogs, most
often aborting bitches,3 accidental laboratory infections,9
and by unknown sources, and have been described with a
wide range of clinical presentations and disease sever-
ity.7,8,10
The annual transport and exchange of hundreds of thou-
sands of dogs between states without regulated testing for B.
canis has resulted in significant losses to the dog industry and
has increased human exposure to this potentially zoonotic
pathogen. Our purpose is to identify a molecular method for
use in backward source tracing, which may encourage reg-
ulation and accountability, thus helping the dog industry to
curb the spread of canine brucellosis.
Materials and methods
Epidemiologic data and pathology
Canine brucellosis outbreaks in three Wisconsin dog kennels
(A, B and C) were examined. Owners and staff, veterinarians,
and animal health and welfare regulatory personnel were
interviewed for information regarding breeding facilities,
canine purchase, breeding and sales practices, and B. canis
control efforts in Wisconsin. Diagnoses of dogs from A and B
kennel outbreaks were made by necropsy, tissue culture and
histopathology of aborted fetuses. Necropsy with bacterial
culture from tissues was used to confirm B. canis in adult dogs
in kennel C.
Serologic and bacteriological analysis
Serum samples from the three outbreaks, as well as serologic
data referenced from Wisconsin Veterinary Diagnostic
Laboratory (WVDL) archives from 1995 to 2005 were
reviewed. Serum samples were screened for B. canis using
a rapid slide agglutination test (RSAT). Positive samples were
then subjected to a 2-mercaptoethanol RSAT, provided with
the same test kit (canine brucellosis antibody test kit;Synbiotics Corporation, San Diego, CA, USA). Samples that
remained positive after this modified procedure were con-
sidered positive for B. canis.
Blood and tissue bacterial culture was used for confirma-
tion of seropositive kennels and individual dogs. The bacteria
were cultured aerobically and the identity confirmed by
standard biochemical tests.
Molecular methods
Ribotyping using the restriction endonucleases PvuII, EcoRI,
SspI, and PstI and outer membrane protein analysis (OMPA)
were performed using previously published protocols.11,12
Pulsed-field gel electrophoresis (PFGE) using the restriction
endonucleases PvuII and XbaI was performed according to the
following protocol. Bacteria were grown aerobically in 5 ml
of tryptic soy broth (BBL) at 37 8C. Three hundred microliters
of each sample was transferred into a sterile microfuge tube
and the cells were harvested by centrifugation at 11 000 rpm
for 2 min. Cells were then resuspended in 200 ml of TE buffer
(10 mM Tris-HCl, 10 mM EDTA, pH 7.4) followed by the addi-
tion of 200 ml of 1.2% low melting temperature agarose. The
suspension was immediately transferred into disposable plug
mold and allowed to solidify. Plugs were incubated in TE
buffer containing 5 mg/ml lysozyme for 3 h at 37 8C. Cells
were then treated overnight at 50 8Cwith the same volume of
solution containing 100 mg proteinase K/ml and washed three
times with 1 ml of cold TE buffer per wash. Restriction
endonucleases were used according to the manufacturer’s
instructions (Promega). The fragments were resolved by
PFGE within electrophoresis grade agarose (1.1%) by using
a CHEF-DR III system (Bio-Rad). The following parameters
were used: running time, 18.5 h; gradient, 63 milliamps;
included angle, 120 8C; initial switch time, 1.0 s; final switch
time, 12.0 s; final shape, non-linear; ramp v/cm, 6. The gels
were stained with ethidium bromide, destained in distilled
water, and photographed under UV light. A lambda marker
(Promega G3011) was used as the molecular weight standard.
Gas chromatographic and dendrogram analyses on whole
cell fatty acid methyl esters (cellular fatty acid profiling,
CFAP) using Sherlock MIS Software were performed at the
MIDI facility (Microbial ID, Inc., Newark, DE, USA) using
previously published protocols.13
Results
Interviews revealed a regular, brokered trade route for the
purchase and sale of breeding dogs between Wisconsin and
Missouri (WI—MO route) in which health certificates are
obtained and B. canis testing is not performed. All three
of the Wisconsin outbreaks followed purchase of new breed-
ing dogs through this route.
From 1995 to 1996 a total of 510 serum samples were
tested for B. canis at WVDL and 10 (1.96%) were identified as
positive. The number of requests for B. canis serology at the
WVDL dropped sharply from 1996 to 1997, but has steadily
risen since then. From 2003 to 2004 a total of 174 samples
were tested and eight (4.60%) were positive. The outbreak at
kennel C resulted in a large increase in submissions to 317 in
the first three months of 2005, with 85 (26.80%) positive
samples.
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Figure 3 Example of Brucella canis isolate outer membrane
protein profile. See details in Table 1.
Figure 1 Example of Brucella canis isolate ribotyping using
SspI. See details in Table 1.
Figure 2 Example of Brucella canis isolate PFGE using PvuII.
See details in Table 1.
Figure 4 Dendrogram analysis of fatty acid profiles for
Table 1 Brucella canis isolates and their sources
Isolate ID Lane Number of
1. 918270 1—3 3; Abdomin
2. 866568 4 1; Fetal lun
3. M05-39757 5—8 4; Uterus a
4. M05-46984 9—11 3; Blood
5. M05-49529 12 1; Blood
6. M05-55455 13 1; Blood
7. 870018 14 1; Mixed fe
8. 57 15 1; Unknown
9. 3192 16 1; Unknown
10. H966 17 1; Unknown
11. Hog 18 1; Unknown
WI, Wisconsin; MO, Missouri; AK, Arkansas; CDC, Centers for Disease CRibotyping results using SspI (Figure 1), EcoRI, PvuII and
PstI (results not shown) as restriction endonucleases revealed
that all of the isolates detailed in Table 1 shared genetic
identity. Results from PFGE (Figure 2) and OMPA (Figure 3)
showed the same homologous results between the isolates.
Only when CFAP was employed were variations between
the isolates identified. Dendrogram analysis using Sherlock
software showed two distinct strains, identified as Northern
and Southern (Figure 4). All of the Missouri and Arkansas
isolates were Southern strain. The isolates from the SplitterBrucella canis isolates 1—11. See details in Table 1.
samples and origin Location
al swabs Kennel B — WI
g and intestine Kennel A — WI
nd placenta Kennel C — WI
MO — 1
AK
MO-2
tal tissues WI
Splitter lab — CDC
Splitter lab — isolate — 1
Splitter lab — isolate — 2
Splitter lab — isolate — 3
ontrol and Prevention.
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additional Wisconsin case (870018), were Northern strain.
Both the Northern and Southern strains were identified in the
same brucellosis outbreak at Wisconsin kennel B.
Discussion
In the USA there is a large and growing dog industry that exists
with minimal regulation. Profitability is based on high volume
breeding and the subsequent sale of puppies, stud dogs, and
breeding bitches. Canine brucellosis is an infectious, vener-
eal transmitted bacterial disease perfectly adapted to the
production goals of the dog industry. The common practices
of using outside dogs for breeding, and frequently buying,
selling and trading breeding dogs without testing for B. canis
have propagated this disease. The interstate purchase of
dogs through the WI—MO route was temporally linked to
the three Wisconsin kennel outbreaks that we investigated,
and WVDL submissions suggest that B. canis is on the rise in
Wisconsin dog kennels. Similar reports of increasing serology
submissions and positive cases in other states indicate the
disease is pervasive in dog kennels in the USA.14,15
Although canine brucellosis is a reportable disease, accu-
rate state-by-state serologic data are not available. This is
due in part to serologic testing being conducted in out-of-
state diagnostic laboratories or in-house by practitioners who
may not report positive cases to state agencies.
Though federal dog kennel licensure is controlled by the
United States Department of Agriculture (USDA), the dog
industry is dissociated from agriculture, where an effective
Brucella abortus eradication program for cattle has been in
place in the USA since 1954.16 Because of the absence of
regulated B. canis testing, the highly infectious nature of B.
canis, and an industry that is willing to tolerate infection, we
do not anticipate that this disease will diminish in the canine
population without intervention similar to that employed in
the cattle industry. Regulation would be dependent on state-
to-state enforcement of kennel licensing to designate dog
breeding facility locations. Once facilities are identified,
required testing for B. canis prior to the sale and interstate
transport of dogs could be implemented.
The propagation of B. canis not only impacts the health
and welfare of dogs, but is also a public heath concern.3,6—
8,10,17 Common clinical symptoms in humans infected with B.
canis include fever and headaches, often accompanied by
lymphadenopathy.3,8 Accurate serologic data on human
exposure to B. canis is lacking because serologic screening
in humans is generally directed against B. abortus, which
does not cross-react with B. canis.6—8,17 Further, it is
unknown how many subclinical and mild human infections
resolve without diagnostic investigation.
Published serologic surveys of B. canis in the USA have
looked at pound dogs, animal shelter workers, veterinar-
ians,18 and military recruits,19 and there are reports that
include serologic data from newborn infants, blood donors,
hospital employees and hospitalized patients.6 These studies
suggest a relatively low prevalence when compared to
reports from Mexico and Argentina,6,7,20 but they have not
included the populations most at risk in the USA, which are
those closely tied to the dog industry. These populations
include breeding kennel owners and employees, and those
dogs specifically used for breeding. This select group isrepeatedly exposed to highly infectious materials when B.
canis outbreaks occur.
Difficulties in species differentiation due to limited
genetic diversity in the genus Brucella are well documen-
ted.21,22 It is therefore not surprising that the commonly used
molecular-based methods for bacterial strain differentia-
tion, including ribotyping, PFGE and OMPA21,23—26, failed to
discriminate B. canis isolates. Using CFAP we were able to
discriminate our isolates into Northern and Southern strains,
and as we expand our database with wider geographic sam-
pling we expect we will find additional regional isolate types.
Both the Northern and Southern strains were identified in the
brucellosis outbreak at Wisconsin kennel B following pur-
chase of infected dogs from Missouri. This finding suggests
that the Missouri dogs were the source of the Southern strain
in this kennel. However, additional data necessary to docu-
ment the introduction of the Southern strain, such as analysis
of isolates from kennel B prior to the Missouri dog purchases,
were not available. In the absence of regulated B. canis
testing, subjecting isolates to CFAP with dendrogram analysis
when outbreaks occur, and maintaining kennel isolate
records may prove to be valuable tools in canine brucellosis
outbreak investigations.
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